Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_assertion evidence source_evidence_literature NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_assertion SIO_000772 19459784 NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_assertion wasDerivedFrom befree-20140225 NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_assertion wasGeneratedBy ECO_0000203 NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.